| Application no. and date | 20781202.5 (espacenet) (Federated) (European Patent Register), 20200914 | | Patent/reg. no. and date | DK/EP 4161528, 20251105 | | Publication date | 20230412 | | Priority no. and date | US 202063034214 P, 20200603 | | EP pub. no. and date |
EP 4161528 20230412 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington, DE 19803, US | | Applicant ref. no. | V497237DK00 | | Inventor | STUBBS, Matthew,
Wilmington, Delaware 19803, US,
LIU, Phillip C.,
Wilmington, Delaware 19803, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 31/538 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATION AF RUXOLITINIB MED INCB057643 TIL ANVENDELSE VED BEHANDLING AF MYELOPROLIFERATIVE NEOPLASMER | | Int. application no. | US2020050753 | | Int. publication no. | WO2021247064 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
